Journal of Clinical Bioinformatics is an open access, peer-reviewed online journal publishing original research on all aspects of the development of evidence-based approaches in bioinformatics and computational medicine, including data integration, methodologies, tools and models, for clinical and translational medicine.

JCBi aims to elucidate how genetic, biological and medical information can be applied to the development of personalized healthcare, medication and therapies. JCBi is a forum for the translation of bioinformatics and computational methods into clinical and medical applications, as well as the advancement of our understanding of the molecular and cellular and regulatory mechanisms of disease.

This journal also has two sections:

Editors-in-Chief

  • Lance Liotta, George Mason University
  • Xiangdong Wang, Fudan University/Lund University

Society affiliations

The Journal of Clinical Bioinformatics is affiliated with the International Society of Translational Medicine.

Articles

There has been an error retrieving the data. Please try again.

Latest news

Call for papers

Newly launched section on "Imaging Bioinformatics" is now accepting submissions. Please read the Call for Papers for more details.

JCBi is accepting submissions on the new series on Biomarkers in human disease. The call for papers highlights the key topics for the series and introduces the series co-Editors.

Article collecton

Biomarkers in human disease

Edited by: Prof Christian Baumgartner, Dr William CS Cho, Prof Armin Graber, Dr Gregory Lewis, Gerald Lushington, Dr Pablo Moscato


Cancer bioinformatics: bioinformatic methods, network biomarkers and precision medicine

Edited by: Xiangdong WANG


Pulmonary Bioinformatics: Mechanism, Biomarkers and Therapies

Edited by: Dr Galina Bogatkevich, Prof Richard Gronostajski, Prof Yoshinori Marunaka, Prof Xiangdong Wang, Dr Yan Xu

Society information

International Society for Translational Medicine logo

The International Society for Translational Medicine (ISTM) invite all JCBi scientists to become society members.


The International Society for Translational Medicine (ISTM) is a non-profit organization dedicated to communication and cross-fertilization among clinicians and researchers from all science fields with an interest in translational medicine. ISTM provides a platform to bring together clinicians, scientists and researchers from all biomedical fields, as well as providing a forum for interdisciplinary exchange of current knowledge and concepts on translational medicine through the society’s membership, professional development programs and conferences. ISTM accelerates the development and clinical application of new therapeutic strategies and diagnostic tools.


ISTM promotes the interaction and co-operation among physicians, scientists, researchers, policy makers, investors, business developers in academics, industries, funding agencies and governments. ISTM also provides professional recognition for engagement in translational medicine and promotes outstanding and innovative studies in the field of translational medicine. ISTM mainly focuses on cellular & molecular medicine, applied immunology, molecular imaging, regenerative medicine, drug discovery and development, biomaterials & clinical application, neurosciences, omics science, and oncology.


More information can be found at www.istmed.org.

Submit a manuscript Sign up for article alerts Contact us Support

Email updates

Receive periodic news and updates relating to this journal straight to your inbox.

Indexed by

  • CAS
  • DBLP
  • DOAJ
  • Google Scholar
  • Index Copernicus
  • PubMed
  • PubMed Central
  • Scopus

View all

ISSN: 2043-9113